ALFA Finder| Revenue growth | 19.5% YoY for FY26; 26.6% YoY for Q4. |
|---|---|
| Margins | EBITDA margin at 41.4%, outperforming 40% guidance. |
| Demand visibility | Strong wellness segment growth (32.2% YoY in Q4). |
| Management confidence | High; cited disciplined execution and brand acceptance in new markets. |
Growth
FY26 revenue grew 19.5% YoY to ₹8,142 Mn; PAT up 20.3% to ₹1,730 Mn. Q4 revenue grew 26.6%.
Outlook
Guided for 4-5 new hubs and 10-12 spokes in FY27. Plans advanced genomic testing and automated lab upgrades.
Risks
Competition in diagnostic pricing; execution risks in scaling newer geographies like Pune and West Bengal.
Earnings Call filed with NSE, NSE: VIJAYA. Summary written with AI assistance from the document.
Vijaya Diagnostic Centre Ltd: key numbers
- Share price
- ₹1,422.70
- Market cap
- ₹14,653 Cr
- Revenue (annual)
- ₹814.2 Cr
- Net profit (annual)
- ₹173.0 Cr
- P/E (TTM)
- 71.9×Sector 54.5×
- Promoter holding
- 52.46%-0.05% QoQ
- FII holding
- 10.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vijaya Diagnostic Centre Ltd
All →Vijaya Diagnostic Centre Earnings Call Transcript: Key Takeaways
Vijaya Diagnostic delivered strong Q2 growth, leveraging operating leverage and CGHS tariff revisions to expand margins significantly despite aggressive network expansion.
- Call
- Guides 20% growth
Vijaya Diagnostic Centre Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹2,554 Mn (+26.7%), EBITDA ₹1,128 Mn (44.1% margin), PAT ₹595 Mn (23.3%). Strategy: hub-and-spoke densification, Bengaluru/Hyderabad hubs, Guwahati entry.
Vijaya Diagnostic Centre Results Update
Vijaya Diagnostic's Q2 FY27 press release reports revenue up 26.7% and PAT up 37.4% year-on-year. It also notes an agreement to acquire Arya Wellness Centre in Guwahati.
Vijaya Diagnostic Centre Management Change
Vijaya Diagnostic Centre appointed Rahul Jain as Company Secretary and Compliance Officer, designated KMP, effective November 03, 2026. The appointment follows the Nomination and Remuneration Committee's recommendation.
Vijaya Diagnostic Centre Q2 FY27 Results: Net Profit ₹59.5 Cr, Up 37.4% YoY
Vijaya Diagnostic Centre Ltd reported revenue from operations of ₹255.4 Cr (+26.7% YoY) and net profit of ₹59.5 Cr (+37.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹59.5 Cr · +37.4% YoY
Vijaya Diagnostic Centre Board Meeting Date
Vijaya Diagnostic Centre scheduled a board meeting for 3 Nov 2026 to approve unaudited Q1 and H1 FY27 results. No financial figures or material decisions are disclosed in this notice.